Medtronic Increased Its Fiscal Year 2024 Organic Revenue Growth Guidance From The Prior 4.75% To 4.75%-5%; Revenue Growth On A Reported Basis Would Be 2.9%-3.3%
Portfolio Pulse from Benzinga Newsdesk
Medtronic has revised its fiscal year 2024 organic revenue growth guidance upwards from the initial 4.75% to a new range of 4.75%-5%. The company now expects revenue growth on a reported basis to be between 2.9% and 3.3%.
February 20, 2024 | 11:49 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic has increased its fiscal year 2024 organic revenue growth guidance, indicating a positive outlook for the company's financial performance.
Raising the organic revenue growth guidance suggests that Medtronic is experiencing stronger than expected demand for its products and services, which is a positive indicator for the company's financial health and future stock performance. Investors typically view such upward revisions positively, as they imply better future earnings potential.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100